These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3967454)

  • 21. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
    Debbas NM; Du Cailar C; Sassine A; Derancourt J; Demaille JG; Puech P
    Eur J Clin Invest; 1983 Apr; 13(2):123-7. PubMed ID: 6409635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myocardium and plasma levels of amiodarone and its N-monodeethylated metabolite].
    Marchiset D; Egre A; Baille Y; Cano JP; Serradimigni A
    Therapie; 1983; 38(1):114-5. PubMed ID: 6867994
    [No Abstract]   [Full Text] [Related]  

  • 24. Amiodarone pharmacokinetics.
    Holt DW; Tucker GT; Jackson PR; Storey GC
    Am Heart J; 1983 Oct; 106(4 Pt 2):840-7. PubMed ID: 6613830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 26. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog.
    Latini R; Reginato R; Burlingame AL; Kates RE
    Biomed Mass Spectrom; 1984 Sep; 11(9):466-71. PubMed ID: 6509156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bioavailability of a premixed, ready-to-use formulation of intravenous amiodarone with traditional admixture in healthy subjects.
    Cushing DJ; Adams MP; Cooper WD; Agha B; Souney PF
    J Clin Pharmacol; 2012 Feb; 52(2):214-21. PubMed ID: 21257800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    Kannan R; Miller S; Singh BN
    Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat.
    Fruncillo RJ; Bernhard R; Swanson BN; Vlasses PH; Ferguson RK
    J Pharm Pharmacol; 1985 Oct; 37(10):729-31. PubMed ID: 2867144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of amiodarone.
    Tucker GT; Jackson PR; Storey GC; Holt DW
    Eur J Clin Pharmacol; 1984; 26(4):533-4. PubMed ID: 6734712
    [No Abstract]   [Full Text] [Related]  

  • 36. A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):339-45. PubMed ID: 6885204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
    Jardan YA; Brocks DR
    Biopharm Drug Dispos; 2016 Sep; 37(6):345-51. PubMed ID: 27194397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herb-drug pharmacokinetic interaction between carica papaya extract and amiodarone in rats.
    Rodrigues M; Alves G; Francisco J; Fortuna A; Falcão A
    J Pharm Pharm Sci; 2014; 17(3):302-15. PubMed ID: 25224345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
    Santostasi G; Fantin M; Maragno I; Gaion RM; Basadonna O; Dalla-Volta S
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):385-90. PubMed ID: 2438499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.